Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Undervalued Biotech Stocks to Buy for Big-Time Returns

By Josh Enomoto, InvestorPlace Contributor

The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive.

Boing! 7 Undervalued Stocks That Could Surprise the Skeptics.

By Josh Enomoto, InvestorPlace Contributor

The market previously supported a higher multiple for these undervalued stocks, making them attractive contrarian targets.

Vroom! 3 EV Stocks With the Potential to Outrun the Competition.

By Josh Enomoto, InvestorPlace Contributor

Although Rivian should be the beneficiary of its own deal with Volkswagen, these other EV stocks are the ones to look at.

3 MedTech Stocks to Buy for Healthy Gains

By Josh Enomoto, InvestorPlace Contributor

With innovations in healthcare moving at a rapid clip, investors should consider these enticing MedTech stocks to buy.

The Next Big Winners: 3 Up-and-Coming Stocks With Strong Potential

By Josh Enomoto, InvestorPlace Contributor

While these up-and-coming stocks don’t command much of the spotlight, they could see significant returns down the line.

Load More